Parisa Aslani, FIP’s new Australian vice-president, has spoken out about the pharmacist’s role in patient safety at the launch of a new policy statement
Programs that allow pharmacists to access patients’ clinical information, non-punitive national systems for reporting, monitoring, analysing and disseminating safety events, safety indicators and benchmarks, and national standards and guidelines are key recommendations for improving patient safety in a new Statement of Policy released by the International Pharmaceutical Federation (FIP).
FIP is currently holding its Virtual Congress for 2020.
“Patient safety has become a global emergency,” said Parisa Aslani, FIP vice president and professor in medicines use optimisation at The University of Sydney, Australia.
“Medication safety is a large component of this and encompasses preventing medication errors and medication-related harm, particularly in relation to high-risk medications and polypharmacy, and optimising safe medication use at each stage of a patient’s medication-use journey, notably at the transitions of care.
“The role of pharmacists and pharmacy teams in patient safety requires recognition and support by healthcare organisations and regulatory bodies.”
The statement sets out recommendations for governments, policy makers, FIP member organisations, pharmacists, the support workforce and the pharmaceutical industry in areas of policy, advocacy, training and resources.
It also expresses FIP’s commitment to ensure that medication safety remains high on the agenda of world health and healthcare professional organisations, as well as national pharmacy organisations.
“Our goal is to increase the safe and effective use of medications, prevent errors and decrease the risk of harm associated with health care.
“FIP encourages all healthcare professionals and other key stakeholders, including patients and their caregivers, managers, policy makers and educators, to consider designing and optimising services collaboratively to improve patient safety,” Prof Aslani said.
The new FIP Statement of Policy is based on the reference document “Patient safety: Pharmacists’ role in ‘Medication without harm’” published last month.
It is available here.